Jilei Zhang — Shandong University

Area of research

Hematology · Psychiatry and Mental health

Research interest

Research interests include Medicine, Cytarabine, Venetoclax, Internal medicine, Induction chemotherapy, and Daunorubicin.

Recent publications

Venetoclax combined with daunorubicin and cytarabine (2 + 6) in acute myeloid leukemia: Updated results of a phase II trial

Hematological Oncology 2024cited by 1position: middledoi

Venetoclax combined with daunorubicin and cytarabine (2 + 6) as induction treatment in adults with newly diagnosed acute myeloid leukemia: a phase 2, multicenter, single-arm trial

Experimental Hematology and Oncology 2023cited by 16position: middledoi

Venetoclax Combined with Daunorubicin and Cytarabine (2 + 6) as Induction Treatment in Adults with Newly Diagnosed Acute Myeloid Leukemia: A Phase 2, Multicenter Trial, Single-Arm Trial

SSRN Electronic Journal 2023cited by 0position: middledoi

Venetoclax Combined with Daunorubicin and Cytarabine (2 + 6) in Acute Myeloid Leukemia: Updated Results of a Phase II Trial

Blood 2023cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Hematology · Psychiatry and Mental health →